Stocks
Odyssey Therapeutics, Inc.ODTX
NASDAQHealthcareBiotechnology$19.60
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing small molecule therapeutics for autoimmune diseases and oncology. Its pipeline targets validated pathways with next-generation chemistry, and investors track it for its progress in advancing multiple candidates through early-stage trials.
52W Range: $15.10-$29.05
Congressional Interest in Odyssey Therapeutics, Inc. (ODTX)
No congressional trades have been disclosed for Odyssey Therapeutics, Inc. (ODTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ODTX?
No congressional trades found for this stock.